357 related articles for article (PubMed ID: 22788994)
41. Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site.
Durdagi S; Şentürk M; Ekinci D; Balaydın HT; Göksu S; Küfrevioğlu Öİ; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem; 2011 Feb; 19(4):1381-9. PubMed ID: 21282059
[TBL] [Abstract][Full Text] [Related]
42. Carbonic anhydrases as drug targets--an overview.
Supuran CT
Curr Top Med Chem; 2007; 7(9):825-33. PubMed ID: 17504127
[TBL] [Abstract][Full Text] [Related]
43. Carbonic anhydrase inhibitors drug design.
McKenna R; Supuran CT
Subcell Biochem; 2014; 75():291-323. PubMed ID: 24146385
[TBL] [Abstract][Full Text] [Related]
44. Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.
Nishimori I; Minakuchi T; Onishi S; Vullo D; Scozzafava A; Supuran CT
J Med Chem; 2007 Jan; 50(2):381-8. PubMed ID: 17228881
[TBL] [Abstract][Full Text] [Related]
45. S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases.
Lopez M; Paul B; Hofmann A; Morizzi J; Wu QK; Charman SA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
J Med Chem; 2009 Oct; 52(20):6421-32. PubMed ID: 19827837
[TBL] [Abstract][Full Text] [Related]
46. 3D QSAR selectivity analyses of carbonic anhydrase inhibitors: insights for the design of isozyme selective inhibitors.
Weber A; Böhm M; Supuran CT; Scozzafava A; Sotriffer CA; Klebe G
J Chem Inf Model; 2006; 46(6):2737-60. PubMed ID: 17125213
[TBL] [Abstract][Full Text] [Related]
47. Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV).
Innocenti A; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2008 Mar; 18(5):1583-7. PubMed ID: 18242985
[TBL] [Abstract][Full Text] [Related]
48. In vitro inhibition of α-carbonic anhydrase isozymes by some phenolic compounds.
Oztürk Sarikaya SB; Topal F; Sentürk M; Gülçin I; Supuran CT
Bioorg Med Chem Lett; 2011 Jul; 21(14):4259-62. PubMed ID: 21669522
[TBL] [Abstract][Full Text] [Related]
49. Carbonic anhydrase inhibitors. Regioselective synthesis of novel series 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII.
Brzozowski Z; Sławiński J; Vullo D; Supuran CT
Eur J Med Chem; 2012 Oct; 56():282-91. PubMed ID: 22910138
[TBL] [Abstract][Full Text] [Related]
50. Discovering isozyme-selective inhibitor scaffolds of human carbonic anhydrases using structural alignment and de novo drug design approaches.
Xiang F; Xiang J; Fang Y; Zhang M; Li M
Chem Biol Drug Des; 2014 Feb; 83(2):247-58. PubMed ID: 24112770
[TBL] [Abstract][Full Text] [Related]
51. The zinc coordination pattern in the η-carbonic anhydrase from Plasmodium falciparum is different from all other carbonic anhydrase genetic families.
De Simone G; Di Fiore A; Capasso C; Supuran CT
Bioorg Med Chem Lett; 2015 Apr; 25(7):1385-9. PubMed ID: 25765908
[TBL] [Abstract][Full Text] [Related]
52. Insights towards sulfonamide drug specificity in α-carbonic anhydrases.
Aggarwal M; Kondeti B; McKenna R
Bioorg Med Chem; 2013 Mar; 21(6):1526-33. PubMed ID: 22985956
[TBL] [Abstract][Full Text] [Related]
53. Kinetically Selective Inhibitors of Human Carbonic Anhydrase Isozymes I, II, VII, IX, XII, and XIII.
Talibov VO; Linkuvienė V; Matulis D; Danielson UH
J Med Chem; 2016 Mar; 59(5):2083-93. PubMed ID: 26805033
[TBL] [Abstract][Full Text] [Related]
54. Catalysis and inhibition of human carbonic anhydrase IV.
Baird TT; Waheed A; Okuyama T; Sly WS; Fierke CA
Biochemistry; 1997 Mar; 36(9):2669-78. PubMed ID: 9054574
[TBL] [Abstract][Full Text] [Related]
55. Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c.
Carta F; Maresca A; Covarrubias AS; Mowbray SL; Jones TA; Supuran CT
Bioorg Med Chem Lett; 2009 Dec; 19(23):6649-54. PubMed ID: 19846301
[TBL] [Abstract][Full Text] [Related]
56. Carbonic anhydrase inhibitors. Identification of selective inhibitors of the human mitochondrial isozymes VA and VB over the cytosolic isozymes I and II from a natural product-based phenolic library.
Davis RA; Innocenti A; Poulsen SA; Supuran CT
Bioorg Med Chem; 2010 Jan; 18(1):14-8. PubMed ID: 19962903
[TBL] [Abstract][Full Text] [Related]
57. Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide-isozyme II adduct.
Temperini C; Cecchi A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2008 Apr; 18(8):2567-73. PubMed ID: 18374572
[TBL] [Abstract][Full Text] [Related]
58. Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity.
Abdel-Hamid MK; Abdel-Hafez AA; El-Koussi NA; Mahfouz NM; Innocenti A; Supuran CT
Bioorg Med Chem; 2007 Nov; 15(22):6975-84. PubMed ID: 17822907
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of Bacterial Carbonic Anhydrases as a Novel Approach to Escape Drug Resistance.
Capasso C; Supuran CT
Curr Top Med Chem; 2017; 17(11):1237-1248. PubMed ID: 28049405
[TBL] [Abstract][Full Text] [Related]
60. (In)organic anions as carbonic anhydrase inhibitors.
De Simone G; Supuran CT
J Inorg Biochem; 2012 Jun; 111():117-29. PubMed ID: 22192857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
